**Summary**
Tekcapital plc, a UK-based intellectual property investment group, released its unaudited half-yearly report for the period ending June 30, 2025, highlighting significant achievements and strategic progress. The company reported record net assets of $77.4 million, a 10% increase from the previous period, driven by portfolio appreciation and disciplined capital allocation. Despite macroeconomic volatility, Tekcapital maintained its NAV per share at $0.33, demonstrating portfolio resilience.
**Key Financial Highlights**
**Record Net Assets:** $77.4 millionup 10% from December 2024.
**NAV per Share** Maintained at $0.33 despite market fluctuations.
**Portfolio Valuation** Increased to $68.8 million from $61.5 million in December 2024.
**Revenue** $6.1 million from services and portfolio returns, down from $21.1 million in H1 2024.
**Operating Expenses** Reduced by 50% to $0.7 million, showcasing cost management discipline.
**Profit After Tax** $5.4 million, marking another profitable half-year.
**Fundraising** $2.3 million raised via share placements to support growth initiatives.
**Operational Highlights**
**Microsalt® plc** Achieved record sales, expanded into new markets, and launched Microsalt® Premium. Sales targets were set at $2 million for FY 2025, with potential sales exceeding $5 million in 2026 and $11 million in 2027 for a major product application.
**Guident Ltd** Advanced its remote monitoring platform, secured strategic contracts, and expanded its leadership team. Guident filed for a potential NASDAQ listing, which could significantly increase balance sheet value and enable special dividends.
**Innovative Eyewear Inc (Lucyd)** Launched Reebok Smart Eyewear, grew sales by 49%, and partnered with Eye Recommend to expand into 600+ Canadian optometry stores.
**GenIP plc** Secured a $0.35 million contract in Saudi Arabia, launched a Competitive Intelligence Report, and secured over $981k in Invention Evaluator orders since September 2024.
**Belluscura® plc** Faced working capital constraints but continued to grow demand for its X-PLOR product, with record sales in April 2025.
**Strategic Focus and Future Outlook**
Tekcapital emphasized its strategy of commercializing university technologies, particularly GenAI-centric solutions, to enhance business efficiency and improve quality of life. The company highlighted its portfolio companies progress and their potential to create lasting societal impact. With nearly all portfolio companies listed, Tekcapital has achieved a transformational inflection point, positioning itself for increased returns on invested capital and future growth.
**Post-Period Highlights**
Guident CORP filed its S-1 Registration Statement for a NASDAQ IPO.
Appointed Michael Tesslerformer CEO of BroadSoftto Guidents Board of Directors.
Guident received ISO/IEC 270012022 Certification for cybersecurity and data protection.
Secured contracts with Coastal Waste & Recycling Inc. and the City of Boca Raton for autonomous shuttle services.
**Chairmans Statement**
Dr. Clifford M. Gross, Chairman and CEO, expressed confidence in Tekcapitals strategy and portfolio performance. He emphasized the companys ability to identify and commercialize university innovations, leading to vibrant companies, growing net assets, and increased returns on invested capital. Gross highlighted the potential for special dividends upon material exits and the companys focus on creating lasting value for shareholders.
**Risk Factors**
The report also outlined various risk factors, including intellectual property risks, regulatory challenges, and market competition, which could impact Tekcapitals portfolio companies and overall performance.
In summary, Tekcapitals half-yearly report showcases a company with a strong financial position, disciplined cost management, and a strategic focus on commercializing innovative technologies. With a diverse portfolio of companies making significant strides, Tekcapital is well-positioned for future growth and value creation.
| Metric | H1 2025 (US$) | H1 2024 (US$) | Year Ended 31 Dec 2024 (US$) | Change H1 2025 vs H1 2024 |
|---|---|---|---|---|
| Net Assets | 77,421,221 | 69,818,904 | 70,067,982 | +10.9% |
| Revenue | 6,171,033 | 21,089,172 | 21,185,962 | -70.7% |
| Operating Expenses | 744,841 | 1,482,460 | 1,879,773 | -50.0% |
| Profit After Tax | 5,425,392 | 19,461,328 | 19,156,025 | -72.1% |
| Fundraising | 2,266,339 | 2,525,696 | 3,795,538 | -10.3% |
| Cash and Cash Equivalents | 1,310,032 | 315,960 | 786,290 | +314.6% |
| Total Liabilities | 497,600 | 545,508 | 571,569 | -8.8% |
| Net Asset Per Share (US$) | 0.33 | 0.35 | 0.33 | -5.7% |